3rd Quarter - Report
MEHLMAN CONSULTING, INC. for VIZIENT INC
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to Unapproved Drug Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Health Issues HCR
Healthcare coverage; prescription drug costs; group purchasing issues; drug shortage issues. 340B Drug Pricing Program. COVID-19 supply chain and pharmaceutical, PPE, and other health care supply chain issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Medicare/Medicaid MMM
Healthcare transparency, costs and access to affordable medication and other healthcare items and services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.